Clinical profile of patients with non-alcoholic fatty liver disease and its association with metabolic syndrome
|
|
- Moses Howard
- 6 years ago
- Views:
Transcription
1 International Journal of Advances in Medicine Pande A et al. Int J Adv Med Aug;4(4): pissn eissn Original Research Article DOI: Clinical profile of patients with non-alcoholic fatty liver disease and its association with metabolic syndrome Abhishek Pande*, Vivek Pande Department of General Medicine, NKPSIMS and L. M. Hospital, Digdoh Hills, Hingna Road, Nagpur, Maharashtra, India Received: 06 June 2017 Accepted: 29 June 2017 *Correspondence: Dr. Abhishek Pande, luvabhi386@gmail.com Copyright: the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Background: Non-alcoholic fatty liver disease (NAFLD) is the accumulation of lipid, primarily in the form of triacylglycerols in individuals who do not consume significant amounts of alcohol and other known causes of steatosis, such as certain drugs and toxins, have been excluded. The rising incidence of obesity is associated with health complications. The non-alcoholic fatty liver disease is increasingly being recognized as a major cause of liverrelated morbidity and mortality among 15-40% of the general population. Currently, a liver biopsy is the gold standard method for diagnosing NAFLD. Ultrasonography is relatively inexpensive and widely available in clinical settings. NAFLD is considered to be an integral part of the metabolic syndrome. The present study is designed to study the clinical profile of patients with NAFLD with varying degrees of severity as diagnosed by Ultrasonography and evaluate the relationship between the non-alcoholic fatty liver disease and the metabolic syndrome along with its individual components, as defined by the modified NCEP ATP III criteria. Methods: A cross-sectional study was conducted by Department of Medicine, NKPSIMS and LMH, Nagpur. A total of 100 cases during the study period of February 2015 to January 2016 were included and investigated for metabolic syndrome according to the NCEP ATP 3 Criteria. Results: Total of 100 cases ultrasonographically diagnosed as NAFLD were included in the study and showed 49%, 38% and 13% of cases had grade I, II, and III fatty liver respectively. On physical examination mean BMI was 27.6±4.39 kg/m 2. Mean diastolic blood pressure was 92.87±6.25 and mean systolic blood pressure (mm Hg) 132.0± Out of the 100, patients with NAFLD with metabolic syndrome were 57% and without metabolic syndrome were 43%. The correlation was significant for fasting plasma glucose, diastolic blood pressure, triglycerides, high-density lipoprotein and waist circumference (p<0.05). Conclusions: From the study, it can be concluded that symptoms and signs of NAFLD are non-specific and occur later in the course of the disease hence the physician should have a high index of suspicion in order to detect NAFLD early in the course of the disease. Early detection would help not only in modifying the disease course and delaying its complications. Keywords: Clinical profile, Metabolic syndrome, Non-alcoholic fatty liver disease INTRODUCTION Non-alcoholic fatty liver disease (NAFLD) is defined as the accumulation of lipid, primarily in the form of triacylglycerols in individuals who do not consume significant amounts of alcohol (<20 g ethanol/d). 1 The rising incidence of obesity in today's environment is associated with many obesity-related health complications, including cardiovascular disease, diabetes, hyperlipidemia, hypertension, and nonalcoholic fatty International Journal of Advances in Medicine July-August 2017 Vol 4 Issue 4 Page 1111
2 liver disease. 2 This combination is also recognized as the metabolic syndrome and is characterized by underlying insulin resistance. 3 Non-alcoholic fatty liver disease is increasingly being recognized as a major cause of liverrelated morbidity and mortality among 15-40% of the general population. 4 The overall prevalence of NAFLD in western countries varies from 15-40% and in Asian countries from 9-40%. 5,6 Epidemiological studies suggest the prevalence of NAFLD be around 9-32% in general Indian population, with a higher incidence amongst overweight/obese and diabetic/pre-diabetic patients. 7,8 Published literature on NAFLD from India is sparse. This may be related to the fact that the condition was recognized fairly recently, a presumption that the condition is benign and has a nonprogressive course, a large burden of viral hepatitis in India tends to reduce the priority accorded to this condition. The absence of signs and symptoms and a lack of sensitive and specific diagnostic tests limit the ability to estimate the prevalence of NAFLD. The current epidemics of obesity and diabetes among adults and children residing in both developed and developing countries suggest that prevalence of NAFLD is expected to increase further in future. 9,10 The pathologic picture of the non-alcoholic fatty liver disease, ranging from simple steatosis to steatohepatitis, advanced fibrosis, and cirrhosis, resembles that of alcohol-induced liver disease, but it also occurs in patients who do not abuse alcohol. 10 Nonalcoholic steatohepatitis that is characterized by hepatic steatosis, liver cell injury, hepatic inflammation, fibrosis, and necrosis is believed to be an intermediate stage of the non-alcoholic fatty liver disease. 4 Even in the absence of alcohol intake, patients who have one or more components of the metabolic syndrome with insulin resistance, develop hepatic steatosis due to increased lipolysis and increased delivery of fatty acids from adipose tissue to liver. 4 Fatty liver disease is defined as more than 5% of the hepatocytes containing fat or more than 5% of the liver weight due to fat. 11 Currently a liver biopsy is the gold standard method for diagnosing NAFLD. Compared to invasive biopsy and expensive MRS and CT, ultrasonography (USG) is relatively inexpensive and widely available in clinical settings, although it is unable to detect less than 10% steatosis of hepatocytes. 12 The third report of the national cholesterol education programme expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III [ATP III]) recommended the use of five variables for diagnosing the metabolic syndrome, namely waist circumference, serum triglyceride level, serum high-density lipoprotein (HDL) cholesterol level, blood pressure, and fasting plasma glucose level. 13 Currently, NAFLD is considered to be an integral part of the metabolic syndrome with insulin resistance as a central pathogenic factor. Metabolic syndrome is characterized by the presence of insulin resistance in association with other metabolic abnormalities such as obesity, diabetes, dyslipidemia and hypertension. According to adult treatment panel III (ATP III) criteria, metabolic syndrome is defined by the presence of at least 3 of the 5 criteria, namely obesity, diabetes mellitus, hypertension, low HDL, high triglycerides. 14 The present study was designed to study the clinical profile of patients with NAFLD with varying degrees of severity as diagnosed by Ultrasonography and evaluate the crosssectional relationship between the non-alcoholic fatty liver disease and the metabolic syndrome along with its individual components, as defined by the modified NCEP ATP III criteria. Objectives of this study was to describe the clinical profile of patients with non-alcoholic fatty liver disease and to study the correlation between the non-alcoholic fatty liver disease and metabolic syndrome. METHODS The present cross-sectional study was conducted by Department of Medicine, NKPSIMS and L.M. Hospital, Digdoh Hills, Hingna Road, Nagpur, Maharashtra. A total of 100 cases were included in the study, during the study period of February 2015 to January The patients diagnosed as NAFLD on USG seeking treatment in the Department of Medicine IPD and OPD were included and investigated for metabolic syndrome according to the NCEP ATP 3 criteria. The data was collected during OPD/IPD treatment and was recorded in predesigned and pretested proforma and analyzed. Inclusion criteria All patients diagnosed as NAFLD by abdominal Ultrasonography Age more than 18 years. Exclusion criteria Patients with a history of alcohol intake more than 30 grams/day in males and more than 20 grams/day in females Patients with a history of jaundice or HBsAg positive Patients with history of following drug intake - steroids, synthetic estrogens, heparin, and calcium channel blockers, amiodarone, valproic acid, antiviral agents. 15 Unwilling patients. Patients were included in the study according to the standard criteria accepted by the American Gastroenterology Association i.e., an increase in hepatic echogenicity as a reference, the presence of enhancement and lack of differentiation in the periportal intensity and International Journal of Advances in Medicine July-August 2017 Vol 4 Issue 4 Page 1112
3 the vascular wall due to great hyperechogenicity in the parenchyma. 15 Grade 1: Slight diffuse increase in the fine echoes. Liver appears bright as compared to the cortex of the kidney. Normal visualization of the diaphragm and intrahepatic vessel borders. Grade 2: Moderate diffuse increase in the fine echoes. Slightly impaired visualization of the intrahepatic vessels and diaphragm Grade 3: Marked increase in the fine echoes. Poor or no visualization of intrahepatic vessel borders, diaphragm, and the vessels. Detailed history, anthropometry, and clinical examinations were carried out after taking informed consent of the patient. All patients in the study underwent routine investigations including complete blood counts, blood sugar, liver function tests, HBsAg, anti-hcv, and lipid profile. All patients diagnosed as NAFLD were investigated for metabolic syndrome according to the NCEP ATP III criteria and a relationship between NAFLD and metabolic syndrome was correlated. 10 Metabolic syndrome was diagnosed as per NCEP ATP 3 criteria (three or more of the following): A. Elevated waist circumference (Asian Indian criteria) 16 Men: Equal to or greater than 90 cm Women: Equal to or greater than 80 cm B. Elevated triglycerides: Equal to or greater than 150 mg/dl (1.7 mmol/l) C. Reduced HDL cholesterol Men: Less than 40 mg/dl (1.03 mmol/l) Women: Less than 50 mg/dl (1.29 mmol/l) D. Elevated blood pressure: Equal to or greater than 130/85 mm Hg or use of medication for hypertension E. Elevated fasting glucose: Equal to or greater than 100 mg/dl (5.6 mmol/l) or use of medication for hyperglycaemia. RESULTS A total of 100 cases ultrasonographically diagnosed as NAFLD were included in the study and showed 49%, 38% and 13% of cases had grade I, II, and III fatty liver respectively. Table 1: Distribution of patients according to their clinical and biochemical profiles (n=100). Variable Mean ± SD Age (in year) ±7.22 Body mass index (kg/m2) ±4.39 Waist circumference (cm) ±7.44 Diastolic blood pressure (mm Hg) ±6.25 Systolic blood pressure (mm Hg) ±18.17 Fasting blood sugar (mg/dl) ±62.62 Total cholesterol (mg/dl) ±54.59 Serum triglycerides (mg/dl) ± 77.5 High density lipoprotein (mg/dl) ±9.13 Serum LDL (mg/dl) ±27.44 Serum VLDL (mg/dl) ±6.09 Aspartate amino transferase (u/l) ±31.33 Alanine amino transferase (u/l) ±49.02 Table 2: Distribution of patients according to the prevalence of variables in patients of NAFLD with metabolic syndrome and NAFLD without metabolic syndrome. Variables NAFLD with Metabolic syndrome (N= 57) NAFLD without Metabolic syndrome (N=43) Total P- value Fasting plasma glucose >100 mg/dl 34 (59.64%) 19 (44.18%) 53 <0.05 Hypertension > 130/85 mmhg 24 (42.10%) 14 (32.55%) 38 <0.05 Triglycerides > 150 mg/dl 43 (75.43%) 27 (62.79%) 70 <0.05 HDL M < 40mg/dl F < 50mg/dl Waist circumference M > 90cm F > 80 cm 37 (64.91%) 14 (32.55%) 51 < (50.87%) 15 (34.88%) 44 <0.05 International Journal of Advances in Medicine July-August 2017 Vol 4 Issue 4 Page 1113
4 Table 3: Distribution of patients according to the grades of NAFLD. NAFLD with metabolic syndrome NAFLD without metabolic syndrome Grade I n= 26 Grade II n=22 Grade III n= 9 Grade I n=23 Grade II n=16 Grade III n=4 ALT 41 IU 8 (30.76%) 14 (63.63%) 6 (66.66%) 15 (65.21%) 7 (43.75%) 1 (25%) AST 38 IU 8 (30.76%) 8 (36.36%) 6 (66.6%) 9 (39.13%) 4 (25.00%) 1 (25%) Central obesity (WC) (> 90 cm - M, > 80 cm - F) 9 (34.61%) 16 (72.72%) 4 (44.44%) 9 (39.13%) 5 (31.25%) 1 (25%) Impaired fasting glucose (>100 mg/dl) 9 (34.61%) 20 (90.90%) 5 (55.55%) 10 (43.47%) 7 (43.75%) 2 (50%) Hypertension (130/85 mmhg) 6 (23.07%) 14 (63.63%) 4 (44.44%) 10 (43.47%) 3 (18.75%) 1 (25%) Low HDL (<50 mg/dl- F, 11 (42.30%) 19 (86.36%) 7 (77.77%) 9 (39.13%) 4 (25.00%) 1 (25%) <40 mg/dl- M) Hypertriglyceridemia (>150 mg/dl) 16 (61.53%) 19 (86.36%) 8 (88.88%) 16 (69.56%) 9 (56.25%) 2 (50%) Table 4: Distribution of patients according to the components of metabolic syndrome in patients of NAFLD. NAFLD without metabolic NAFLD with metabolic syndrome Variables syndrome P-value Fasting plasma glucose (mg/dl) ± ±27.28 <0.05 Blood pressure (mm of Hg) Systolic blood pressure ± ±15.82 > 0.05 Diastolic blood pressure 87.21± ±8.14 <0.05 Triglycerides (mg/dl) ± ±73.56 <0.05 High density lipoprotein (mg/dl) 35.10± ±4.76 <0.05 Waist circumference (cm) 86.67± ±7.55 <0.05 Table 1 shows that mean age of the patient was 53.70±7.22 years. On physical examination findings showed the mean BMI was 27.6±4.39 kg/m 2, mean waist circumference was 74.22±7.44 cm. Mean diastolic blood pressure (mm Hg) was 92.87±6.25 and mean systolic blood pressure (mm Hg) 132.0± The mean fasting blood sugar (mg/dl) was ±62.62 and mean total cholesterol (mg/dl) was ±54.59 and mean serum triglycerides (mg/dl) were ±77.5. Table 2 shows that out of 100, patients with NAFLD with metabolic syndrome were 57% and without metabolic syndrome were 43%. The study shows that 53% patients had fasting plasma glucose >100 mg/dl while 38% patients were hypertensive. Maximum 70% patients had triglycerides >150 mg/dl while low serum HDL level was seen in 51% patients and increased waist circumference was found in 44% patients. The difference was statistically significant (p<0.05). Table 3 shows that altered ALT 41 IU was observed in 14 (63.63%) of Grade II of patients with NAFLD with metabolic syndrome. Central obesity was observed in 16 (72.72%) of Grade II patients with NAFLD with metabolic syndrome. While 20(90.90%) Grade II of patients with NAFLD with metabolic syndrome showed impaired fasting glucose (>100 mg/dl). Hypertriglyceridemia (>150 mg/dl) in 16 (69.56%) seen in Grade I of patients with NAFLD without metabolic syndrome. Table 4 shows that mean Fasting plasma glucose (mg/dl) ±45.35 was observed in patients with NAFLD with metabolic syndrome, while mean SBP ±17.56 was observed in patients with NAFLD with metabolic syndrome and the difference was not significant. Mean Hypertriglyceridemia (mg/dl) ± was observed in patients with NAFLD with metabolic syndrome. The correlation was significant for fasting plasma glucose, diastolic blood pressure, triglycerides, high-density lipoprotein and waist circumference (p<0.05). DISCUSSION A total of 100 cases ultrasonographically diagnosed as NAFLD were included in the study and showed 49%, 38% and 13% of cases had grade I, II, and III fatty liver respectively. In the present study, it was observed that mean age of the patient was 53.70±7.22 years. On physical examination mean BMI was 27.6±4.39 kg/m 2 while mean waist circumference was 74.22±7.44 cm. Mean Diastolic blood pressure (mm of Hg) was International Journal of Advances in Medicine July-August 2017 Vol 4 Issue 4 Page 1114
5 92.87±6.25 and mean Systolic blood pressure (mm Hg) 132.0± These results are consistent with studies by Rakesh Gaharwar et al and Animesh Deb et al. 17,18 The mean Fasting blood sugar (mg/dl) was ±62.62 and mean total cholesterol (mg/dl) was ±54.59 while mean Serum triglycerides (mg/dl) were ±77.5 these findings are similar to study by Shivaram Prasad Singh et al and Kwon YM et al. 19,20 In the present study, it was observed that out of 100, patients with NAFLD with metabolic syndrome were 57% and without metabolic syndrome were 43%. The study shows that 53% patients had fasting plasma glucose >100 mg/dl, while 38% patients were hypertensive similar to studies by Rakesh Gaharwar et al and Animesh Deb et al. 17,18 Maximum 70% patients had Triglycerides >150 mg/dl while low Serum HDL level was seen in 51% patients and increased waist circumference was found in 44% patients which were also observed by Yang KC et al and the difference was statistically significant. 21 In the present study, it was observed that altered ALT 41 IU was observed in 14 (63.63%) Grade II NAFLD patients with metabolic syndrome. Central obesity was observed in 16 (72.72%) Grade II NAFLD patients with metabolic syndrome. These findings are consistent with the study by Vendhan R et al and Andrade GC, while 20 (90.90%) Grade II of patients with NAFLD with metabolic syndrome showed impaired fasting glucose (>100 mg/dl). 22,23 Hypertriglyceridaemia (>150 mg/dl) in 16 (69.56%) Grade I of patients with NAFLD without metabolic syndrome. These results are consistent with studies by Gaharwar R et al and Deb A et al. 17,18 In the present study, it was observed that mean Fasting plasma glucose (mg/dl) ±45.35 was observed in patients with NAFLD with metabolic syndrome while mean SBP ±17.56 was observed in patients with NAFLD with metabolic syndrome and the difference was not significant. Mean hypertriglyceridemia (mg/dl) ± was observed in patients with NAFLD with metabolic syndrome. These results are consistent with studies by Gaharwar R et al, Deb A et al and Younossi ZM et al. 17,18,24 CONCLUSION From our study, it can be concluded that symptoms and signs of NAFLD are non-specific and occur later in the course of the disease hence the physician should have a high index of suspicion in order to detect NAFLD early in the course of the disease. Higher prevalence of all the components of metabolic syndrome in cases of NAFLD was observed. Liver biopsy is considered the gold standard for diagnosing NAFLD but is not practical and most patients are not willing to undergo the test. Thus, patients must be evaluated for the presence of NAFLD by abdominal Ultrasonography. Early detection would help in modifying the disease course and delaying its complications. Funding: No funding sources Conflict of interest: None declared Ethical approval: The study was approved by the institutional ethics committee REFERENCES 1. McCullough AJ. The clinical features, diagnosis and natural history of the non-alcoholic fatty liver disease. Clin Liver Dis. 2004;8: Pi-Sunyer FX. The obesity epidemic: pathophysiology and consequences of obesity. Obes Res 2002;10(suppl 2):97S-104S. 3. Haynes P, Liangpunsakul S, Chalasani N. Nonalcoholic fatty liver disease in individuals with severe obesity. Clin Liver Dis. 2004;8: Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346: Farrell GC, Larter CZ. Nonalcoholic Fatty Liver Disease: from Steatosis to cirrhosis. Hepatol. 2006;43:S00-S Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: A global perspective. Semin Liver Dis. 2008;28: Duseja A. Nonalcoholic fatty liver disease in India - a lot done, yet more required. Indian J Gastroenterol. 2010;29: Gupte P, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, Pramanik S, et al. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol. 2004;19: Sanyal AJ. AGA technical review on the nonalcoholic fatty liver disease. Gastroenterol. 2002;123: Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatol. 2003;37: Cairns SR, Peters TJ. Biochemical analysis of hepatic lipid in alcoholic and diabetic and control subjects. Clin Sci (Lond). 1983;65: Machado MV, Cortez-Pinto H. Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. J Hepatol. 2013;58: Prashanth M, Ganesh HK, Vima MV, John M, Bandgar T, Joshi SR, et al. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. J Assoc Physicians Ind. 2009;57: Duseja A, Das A, Kumar K, Dhiman RK, Chawla Y, Das R, et al. Clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (nafld) is different from the West. J Gastroenterol Hepatol. 2006;21:A Agrawal R, Mishra S, Dixit VK, Rai S. Association of non-alcoholic fatty liver disorder with obesity. Indian J Prev Soc Med. 2008;39: Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Chadha D, et al. Consensus Group. Consensus statement for diagnosis of obesity, International Journal of Advances in Medicine July-August 2017 Vol 4 Issue 4 Page 1115
6 abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians Ind. 2009;57: Gaharwar R, Trikha S, Margekar SL, Jatav OP, Ganga PD. Study of clinical profile of patients with non-alcoholic fatty liver disease and its association with metabolic syndrome. J Assoc Phy Ind. 2015;63: Deb A, Chattopadhyay A, Hassan K, Bhattacharya J, Basu M. Clinical profile of patients with nonalcoholic fatty liver disease and its association with metabolic syndrome: a cross-sectional study. IOSR J Dent Med Sci (IOSR-JDMS). 2015;14(12): Singh SP, Kar SK, Panigrahi MK, Misra B, Pattnaik K, Bhuyan P, et al. Profile of patients with incidentally detected non-alcoholic fatty liver disease (IDNAFLD) in coastal Eastern India. Tropical Gastroenterol. 2013;34(3): Kwon YM, Oh SW, Hwang SS, Lee C, Kwon H, Chung GE. Association of non-alcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults. Am J Gastroenterol. 2012;107(12): Yang KC, Hung HF, Lu CW, Chang HH, Lee LT, Huang KC. Association of non-alcoholic fatty liver disease with metabolic syndrome independently of central obesity and insulin resistance. Scientific Reports. 2016; Vendhan R, Amutha A, Anjana RM, Unnikrishnan R, Mohan V. Clinical profile of nonalcoholic Fatty liver disease among young patients with type 1 diabetes mellitus seen at a diabetes specialty center in India. Endocr Pract. 2014;20(12): Andrade GC, Fujise LH, Santana JE Filho, Oliveira F, Silva RC. Non-alcoholic fatty liver disease (NAFLD) in different populations: a clinical and epidemiological study - sample of São José do Rio Preto. Rev Assoc Med Bras. 2016;62(3): Younossi ZM, Otgonsuren M, Venkatesan C, Mishra A. In patients with the non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. Metabol. 2013;62(3): Cite this article as: Pande A, Pande V. Clinical profile of patients with non-alcoholic fatty liver disease and its association with metabolic syndrome. Int J Adv Med 2017;4: International Journal of Advances in Medicine July-August 2017 Vol 4 Issue 4 Page 1116
Clinical Profile of Patients with Non Alcoholic Fatty Liver Disease and its Association with Metabolic Syndrome a cross sectional study
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 14, Issue 12 Ver. IX (Dec. 2015), PP 11-15 www.iosrjournals.org Clinical Profile of Patients with Non
More informationAmerican Journal of Oral Medicine and Radiology
American Journal of Oral Medicine and Radiology e - ISSN - XXXX-XXXX ISSN - 2394-7721 Journal homepage: www.mcmed.us/journal/ajomr PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE AMONG TYPE 2 DIABETIC POPULATION
More informationPrevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus patients in a tertiary care hospital of Bihar
Original Research Article Prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus patients in a tertiary care hospital of Bihar Naresh Kumar 1, Jyoti Kumar Dinkar 2*, Chandrakishore
More informationPrevalence of non-alcoholic fatty liver disease in type-2 diabetes mellitus patients
International Journal of Research in Medical Sciences Patel H et al. Int J Res Med Sci. 2018 Apr;6(4):1322-1326 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Original Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20181290
More informationNon-Alcoholic Fatty Liver Disease and Metabolic Syndrome in Type 2 Diabetes Mellitus Patients in Rajshahi Medical College Hospital
WELCOME Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome in Type 2 Diabetes Mellitus Patients in Rajshahi Medical College Hospital Presented by DR. PRABIR MOHAN BASAK ASSISTANT PROFESSOR DEPARTMENT
More informationPrevalence of diabetes, hypertension, dyslipidemia and obesity in patients of non alcoholic fatty liver
International Journal of Advanced Multidisciplinary Research ISSN: 2393-8870 www.ijarm.com DOI: 10.22192/ijamr Volume 4, Issue 8-2017 Research Article DOI: http://dx.doi.org/10.22192/ijamr.2017.04.08.003
More informationThe effect of aerobic exercise on serum level of liver enzymes and liver echogenicity in patients with non-alcoholic fatty liver disease
Gastroenterology and Hepatology From Bed to Bench. 2013 RIGLD, Research Institute for Gastroenterology and Liver Diseases ORIGINAL ARTICLE The effect of aerobic exercise on serum level of liver enzymes
More informationNonalcoholic Fatty Liver Disease: Definitions, Risk Factors, and Workup
REVIEW REVIEW Nonalcoholic Fatty Liver Disease: Definitions, Risk Factors, and Workup Puneet Puri, M.B.B.S., M.D. and Arun J. Sanyal, M.B.B.S., M.D. Nonalcoholic fatty liver disease (NAFLD) is defined
More informationBackground of the FIB-4 Index in Japanese Non-Alcoholic Fatty Liver Disease
ORIGINAL ARTICLE Background of the FIB-4 Index in Japanese Non-Alcoholic Fatty Liver Disease Takashi Wada and Mikio Zeniya Abstract Objective We investigated the distribution and characteristics of the
More informationAssessment of Liver Stiffness by Transient Elastography in Diabetics with Fatty Liver A Single Center Cross Sectional observational Study
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 6 Ver. IV (June. 2017), PP 49-53 www.iosrjournals.org Assessment of Liver Stiffness by Transient
More informationInternal and Emergency Medicine Official Journal of the Italian Society of Internal Medicine. ISSN Volume 8 Number 3
Hepatic Steatosis Index and Lipid Accumulation Product as middle-term predictors of incident metabolic syndrome in a large population sample: data from the Brisighella Heart Study Arrigo F. G. Cicero,
More informationFREQUENCY OF NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND ITS BIOCHEMICAL DERANGEMENTS IN TYPE II DIABETIC PATIENTS
FREQUENCY OF NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND ITS BIOCHEMICAL DERANGEMENTS IN TYPE II DIABETIC PATIENTS DR. ABDUL JABBAR, MBBS DR. ABDUL BASIT, MBBS DR. HAFIZ MUHAMMAD HANNAN AKBAR, MBBS ABSTRACT
More informationLaboratory analysis of the obese child recommendations and discussion. MacKenzi Hillard May 4, 2011
Laboratory analysis of the obese child recommendations and discussion MacKenzi Hillard May 4, 2011 aka: What to do with Fasting Labs The Obesity Epidemic The prevalence of obesity in adolescents has tripled
More informationCDHNF & NASPGHAN A Partnership for Research and Education for Children s Digestive and Nutritional Health
CDHNF & NASPGHAN A Partnership for Research and Education for Children s Digestive and Nutritional Health Obesity and NAFLD Definitions: Nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver
More informationNONALCOHOLIC FATTY LIVER DISEASE. Non-Alcoholic Fatty Liver Disease (NAFLD) Primary NAFLD. April 13, 2012
NONALCOHOLIC FATTY LIVER DISEASE Kiran Bambha, MD University of Colorado Denver April 13, 2012 Non-Alcoholic Fatty Liver Disease (NAFLD) Primary NAFLD Simple Steatosis Fatty hepatocytes Intracellular fat
More informationNIH Public Access Author Manuscript Am J Med Sci. Author manuscript; available in PMC 2015 January 01.
NIH Public Access Author Manuscript Published in final edited form as: Am J Med Sci. 2014 January ; 347(1):. doi:10.1097/maj.0b013e31828b25a5. Association Between Metabolic Syndrome and Its Individual
More informationDisclosure. Objectives. Smash the Nash: A practical approach to fatty liver disease
Smash the Nash: A practical approach to fatty liver disease Bruce D. Askey, MS, ANP-BC Associate Lecturer North Andover, MA Adult Nurse Practitioner Dept. of Hepatology/Gastroenterology Guthrie Clinic
More informationImproving Access to Quality Medical Care Webinar Series
Improving Access to Quality Medical Care Webinar Series Presented by The Arizona Telemedicine Program and the Southwest Telehealth Resource Center 2015 UA Board of Regents Welcome AZ, UT, CO, NM & NV FLEX
More informationOriginal Article Serum Lipid Profile in Non Alcoholic Fatty Liver Disease Pak Armed Forces Med J 2017; 67 (6):
Open Access Original Article Serum Lipid Profile in Non Alcoholic Fatty Liver Disease Pak Armed Forces Med J 2017; 67 (6): 930-35 COMPARISON OF SERUM LIPID PROFILE IN NON ALCOHOLIC FATTY LIVER DISEASE
More informationDevelopment and validation of a simple index system to predict nonalcoholic fatty liver disease
The Korean Journal of Hepatology 2011;17:19-26 DOI: 10.3350/kjhep.2011.17.1.19 Original Article Development and validation of a simple index system to predict nonalcoholic fatty liver disease Young Jin
More informationHigher non-hdl-cholesterol to HDLcholesterol ratio linked with increased nonalcoholic steatohepatitis
Wang et al. Lipids in Health and Disease (2018) 17:67 https://doi.org/10.1186/s12944-018-0720-x RESEARCH Open Access Higher non-hdl-cholesterol to HDLcholesterol ratio linked with increased nonalcoholic
More informationPatients characteristics associated with better glycemic response to teneligliptin and metformin therapy in type 2 diabetes: a retrospective study
International Journal of Advances in Medicine Gadge PV et al. Int J Adv Med. 2018 Apr;5(2):424-428 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20181082
More informationNon-alcoholic Fatty Liver Disease (NAFLD) and its association with metabolic syndrome and cardiovascular diseases
Non-alcoholic Fatty Liver Disease (NAFLD) and its association with metabolic syndrome and cardiovascular diseases Dr. Meenaxi Sharda 1, Dr. Deepti Yagnik 2, Dr. Anil Soni 3 and Dr. Harish Nigam 4 1 Professor,
More informationInternational Journal Of Basic And Applied Physiology
COMPARATIVE STUDY OF LIVER FUNCTION TESTS IN DIABETES TYPE-2 PATIENTS AND NON-DIABETICS IN GUJARAT Vishaldeep D Gohel*, Betsy Johnson**, Varsha Joshi***, *Tutor,**2 nd Year resident,*** Head of department,
More informationDownloaded from zjrms.ir at 3: on Monday February 25th 2019 NAFLD BMI. Kg/m2 NAFLD
logistic regression Student s t-test P< BMI BMI P< ALT AST P< Email:mkhoshbaten@yahoo.com Kg/m2 NASH RUQ B C II Case-Control II Logistic Regression Chi-Square T-test P< Grade Model 1- A diffuse hyper echoic
More informationAn Evaluation of Candidate Definitions of the Metabolic Syndrome in Adult Asian Indians
Metabolic Syndrome/Insulin Resistance Syndrome/Pre-Diabetes O R I G I N A L A R T I C L E An Evaluation of Candidate Definitions of the Metabolic Syndrome in Adult Asian Indians ANOOP MISRA, MD 1 JASJEET
More informationNonalcoholic Fatty Liver Disease in a Sample of Iranian Women with Polycystic Ovary Syndrome
Original Article Nonalcoholic Fatty Liver Disease in a Sample of Iranian Women with Polycystic Ovary Syndrome Abstract Introduction: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in
More informationEarly life determinants of Non-Alcoholic Fatty Liver Disease and NASH DR JULIANA MUIVA-GITOBU KENYA PAEDIATRIC ASSOCIATION CONFERENCE APRIL 2016.
Early life determinants of Non-Alcoholic Fatty Liver Disease and NASH DR JULIANA MUIVA-GITOBU KENYA PAEDIATRIC ASSOCIATION CONFERENCE APRIL 2016. Outline Definition NAFLD and NASH Magnitude of the problem
More informationWhat is NAFLD?.NASH? Presenter Disclosure Information. Learning Objectives. Case 1: Rob. Questions Pertinent to Rob
Presenter Disclosure Information 5 6pm Nonalcoholic Fatty Liver Disease (NAFLD): Another Obesity-Related Epidemic SPEAKER Elliot Tapper, MD The following relationships exist related to this presentation:
More informationComparative study of metabolic profile of women presenting with polycystic ovary syndrome in relation to body mass index
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Akshaya S et al. Int J Reprod Contracept Obstet Gynecol. 2016 Aug;5(8):2561-2565 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
More informationCLINICAL AND HISTOLOGICAL FEATURES OF NON-ALCOHOLIC STEATOHEPATITIS IN IRANIAN PATIENTS
CLINICAL AND HISTOLOGICAL FEATURES OF NON-ALCOHOLIC STEATOHEPATITIS IN IRANIAN PATIENTS N. Ebrahimi Daryani, Sh. Mirmomen, H. Bahrami, B. Haghpanah and A. Nayerhabibi Department of Gastroenterology, Imam
More informationAssociation between Abnormal Liver Function and Risk Factors for Metabolic Syndrome among Freshmen
Journal of Adolescent Health 41 (2007) 132 137 Original article Association between Abnormal Liver Function and Risk Factors for Metabolic Syndrome among Freshmen Ping-Yun Tsai, M.D. a, Chung-Jen Yen,
More informationAssociations between Bright Pancreas and Features of Metabolic Syndrome
Japan Society of Nigen Dock ORIGINAL ARTICLE Ningen Dock 2012 ; 26 : 935-943 Associations between Bright Pancreas and Features of Metabolic Syndrome Akihiro Obora 1,2), Takao Kojima 1,2), Takahiro Kato
More informationThe Absence of Obstructive Sleep Apnea May Protect against Non- Alcoholic Fatty Liver in Patients Undergoing Bariatric Surgery
The Absence of Obstructive Sleep Apnea May Protect against Non- Alcoholic Fatty Liver in Patients Undergoing Bariatric Surgery The Harvard community has made this article openly available. Please share
More informationAt Least 1 in 5 Patients in Your Practice Have Fatty Liver
At Least 1 in 5 Patients in Your Practice Have Fatty Liver What Can You Tell Your Patients Magnus McLeod MD FRCPC Assistant Professor Dalhousie University 30-NOV-2017 NAFLD Non-Alcoholic Fatty Liver Disease
More informationALT and aspartate aminotransferase (AST) levels were measured using the α-ketoglutarate reaction (Roche,
Supplemental Methods Analytical determinations ALT and aspartate aminotransferase (AST) levels were measured using the α-ketoglutarate reaction (Roche, Basel, Switzerland). Glucose, triglyceride, total
More informationNON-ALCOHOLIC STEATOHEPATITIS AND NON-ALCOHOLIC FATTY LIVER DISEASES
NON-ALCOHOLIC STEATOHEPATITIS AND NON-ALCOHOLIC FATTY LIVER DISEASES Preface Zobair M. Younossi xiii Epidemiology and Natural History of NAFLD and NASH 1 Janus P. Ong and Zobair M. Younossi Understanding
More informationNormal ALT for men 30 IU/L 36% US males abnormal. Abnl ALT. Assess alcohol use/meds. Recheck in 6-8 weeks. still pos
Fatty liver disease Its not just for big boys anymore Ken Flora, MD, FAASLD, FACG, AGAF No disclosures Common situation Normal ALT for men 30 IU/L 36% US males abnormal Normal ALT for women 20 IU/L 28%
More informationFatty Liver Disease A growing epidemic
Fatty Liver Disease A growing epidemic Updates in GIM for Primary Care Don C. Rockey March 9 th, 2018 Disclosures 2018 Research Funding (all to MUSC) NIH/NIDDK Actelion Pharmaceuticals Gilead Sciences
More informationA STUDY OF NON ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME
A STUDY OF NON ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME D. Vasundhara Devi, M. Madhu Latha, A. Sumapreethi, S. S. B. Sharma, K. Priyanka 1. Assistant Professor, Department of Biochemistry,
More informationPancreatic exocrine insufficiency: a rare cause of nonalcoholic steatohepatitis
Pancreatic exocrine insufficiency: a rare cause of nonalcoholic steatohepatitis Naoki Tanaka 1, Akira Horiuchi 2, Takahide Yokoyama 3, Shigeyuki Kawa 1, and Kendo Kiyosawa 1 1 Department of Gastroenterology,
More informationOriginal Article. Significance of Hepatic Steatosis in Chronic Hepatitis B Infection INTRODUCTION
Original Article Bhanthumkomol P, et al. THAI J GASTROENTEROL 2013 Vol. 14 No. 1 Jan. - Apr. 2013 29 Bhanthumkomol P 1 Charatcharoenwitthaya P 1 Pongpaiboon A 2 ABSTRACT Background: Significance of liver
More informationEffect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease
Liver International ISSN 1478-3223 METABOLIC AND STEATOHEPATITIS Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease Hellan K. Kwon 1, Joel K. Greenson
More informationNonalcoholic Fatty Liver Disease in Children: Typical and Atypical
Nonalcoholic Fatty Liver Disease in Children: Typical and Atypical Disclosure Naim Alkhouri, MD discloses the following relationships with commercial companies: Membership in the Speakers Bureau for Alexion
More informationNonalcoholic fatty liver disease in India a lot done, yet more required!
Indian J Gastroenterol (2010) 29:217 225 DOI 10.1007/s12664-010-0069-1 REVIEW ARTICLE Nonalcoholic fatty liver disease in India a lot done, yet more required! Ajay Duseja Received: 1 August 2010 / Accepted:
More informationDIABETES. A growing problem
DIABETES A growing problem Countries still grappling with infectious diseases such as tuberculosis, HIV/AIDS and malaria now face a double burden of disease Major social and economic change has brought
More informationFrequency of Dyslipidemia and IHD in IGT Patients
Frequency of Dyslipidemia and IHD in IGT Patients *Islam MS, 1 Hossain MZ, 2 Talukder SK, 3 Elahi MM, 4 Mondal RN 5 Impaired glucose tolerance (IGT) is often associated with macrovascular complications.
More informationRelationship between psoriasis and non-alcoholic fatty liver disease
Original paper Relationship between psoriasis and non-alcoholic fatty liver disease Krishnasamy Narayanasamy 1, Abarna Devi Sanmarkan 2, Karthick Rajendran 3, Chezhian Annasamy 1, Senthilkumar Ramalingam
More informationThe association between white blood cell subtypes and prevalence and incidence of nonalcoholic fatty liver disease
834477EJI0010.1177/2058739219834477European Journal of InflammationZhang et al. letter2019 Letter to the Editor The association between white blood cell subtypes and prevalence and incidence of nonalcoholic
More informationUMHS-PUHSC JOINT INSTITUTE
Role of Visceral Adiposity in the Pathogenesis of Non-Alcoholic Fatty Liver Disease in Lean versus Obese Patients: A Comparative Study between Patients at UMHS versus PUHSC Lai WEI and Anna LOK W Zhang,
More informationPrevalence of non-alcoholic fatty liver disease (NAFLD) in type 2 diabetic patients in correlation with coronary artery disease
Original Research Article Prevalence of non-alcoholic fatty liver disease (NAFLD) in type 2 diabetic patients in correlation with coronary artery disease Ramulu Pulimaddi 1*, Amruth Rao Parveda 2, Dhanunjaya
More informationNon-Alcoholic Fatty Liver Diseasean underestimated epidemic
Non-Alcoholic Fatty Liver Diseasean underestimated epidemic Amir Shlomai MD,PhD Head, Department of Medicine D The Liver Institute Rabin Medical Center, Beilinson Hospital The IASLD semi-annual meeting-
More informationNon-alcoholic fatty liver disease and associated risk factors among hemodialysis patients
Non-alcoholic fatty liver disease and associated risk factors among hemodialysis patients Sima Golmohamadi Hamid Reza Omrani Nadia Asadi Lotfollah Asgari Zahra Fathi Department of Internal Medicine, School
More information3/20/2011. Body Mass Index (kg/[m 2 ]) Age at Issue (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Mokdad A.H.
U.S. Adults: 1988 Nineteen states with 10-14% 14% Prevalence of Obesity (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Metabolic John P. Cello, MD Professor of Medicine and Surgery, University of California,
More informationNon alcoholic fatty liver and Non alcoholic Steatohepatitis. By Dr. Seham Seif
Non alcoholic fatty liver and Non alcoholic Steatohepatitis By Dr. Seham Seif Definition NAFL describe a common clinicopathological conditions characterized by significant lipid deposition in the hepatocytes
More informationObesity and the Metabolic Syndrome in Developing Countries: Focus on South Asians
Obesity and the Metabolic Syndrome in Developing Countries: Focus on South Asians Anoop Misra Developing countries, particularly South Asian countries, are witnessing a rapid increase in type 2 diabetes
More informationNon alcoholic fatty liver disease and atherosclerosis Raul Santos, MD
Non alcoholic fatty liver disease and atherosclerosis Raul Santos, MD Sao Paulo Medical School Hospital Sao Paulo, Brazil Disclosure Honoraria received for consult and/or speaker : Astra Zeneca, Amgen,
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationTotal risk management of Cardiovascular diseases Nobuhiro Yamada
Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible
More informationFatty liver disease: What do we know?
Fatty liver disease: What do we know? Prof. Dr. Claus Niederau Katholische Kliniken Oberhausen ggmbh St. Josef-Hospital Academic Teaching Hospital University of Duisburg-Essen NAFLD Non-Alcoholic Fatty
More informationNAFLD/NASH. Definitions. Pathology NASH. Vicki Shah PA-C, MMS Rush University Hepatology
NAFLD/NASH Vicki Shah PA-C, MMS Rush University Hepatology Definitions NAFLD Evidence of hepatic steatosis by histology (5%) or imaging No causes for secondary fat accumulation EtOH, Drugs, hereditary
More informationMETABOLIC SYNDROME AND HCV: FROM HCV
METABOLIC SYNDROME AND HCV: FROM THEORY TO PRACTICE HCV Steatosis Insulin resistance Arun J Sanyal M.D. Chairman, Div. of Gastroenterology, Hepatology and Nutrition Virginia Commonwealth University Richmond,
More informationNon-Alcoholic Fatty Liver Disease (NAFLD)
HEPATO-PANCREATO-BILIARY STOMACH CANCER PROGRAM Non-Alcoholic Fatty Liver Disease (NAFLD) Steatosis and Non-Alcoholic Steatohepatitis (NASH) Management Recommendations UCSF Fresno Department of Surgery
More informationLIVER, PANCREAS, AND BILIARY TRACT
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2012;10:1028 1033 LIVER, PANCREAS, AND BILIARY TRACT Prevalence and Indicators of Portal Hypertension in Patients With Nonalcoholic Fatty Liver Disease FLAVIA D.
More informationMetabolic Syndrome and Chronic Kidney Disease
Metabolic Syndrome and Chronic Kidney Disease Definition of Metabolic Syndrome National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III Abdominal obesity, defined as a waist circumference
More informationPrevalence of non-alcoholic fatty liver disease among obese children in North Kerala, India
International Journal of Contemporary Pediatrics Reetha G et al. Int J Contemp Pediatr. 2017 May;4(3):1051-1055 http://www.ijpediatrics.com pissn 2349-3283 eissn 2349-3291 Original Research Article DOI:
More informationMetabolic Syndrome. Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah
Metabolic Syndrome Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah Objectives Be able to outline the pathophysiology of the metabolic syndrome Be able to list diagnostic criteria for
More informationThe role of non-invasivemethods in evaluating liver fibrosis of patients with non-alcoholic steatohepatitis
The role of non-invasivemethods in evaluating liver fibrosis of patients with non-alcoholic steatohepatitis Objectives: Liver biopsy is the gold standard for diagnosing the extent of fibrosis in NAFLD/NASH;
More informationPrevalence of non- alcoholic fatty liver disease among type-2 diabetes mellitus patients A cross-sectional hospital based study
Al Am een J Med Sci 2015; 8(1):50-54 US National Library of Medicine enlisted journal ISSN 0974-1143 ORIGI NAL ARTICLE C O D E N : A A J MB G Prevalence of non- alcoholic fatty liver disease among type-2
More informationAssessment of NAFLD cases and its correlation to BMI and metabolic syndrome in healthy blood donors in Kerman
Gastroenterology and Hepatology From Bed to Bench 2012 RIGLD, Research Institute for Gastroenterology and Liver Diseases ORIGINAL ARTICLE Assessment of NAFLD cases and its correlation to BMI and metabolic
More informationInsulin resistance and its associated comorbidities in young individuals: a HOMA study
International Journal of Advances in Medicine Ahamed IHB et al. Int J Adv Med. 2017 Feb;4(1):225-229 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20170116
More informationCorrelation between severity of ultrasonographic nonalcoholic fatty liver disease and cardiometabolic risk among Filipino wellness patients
J Cardiovasc Thorac Res, 2017, 9(2), 85-89 doi: 10.15171/jcvtr.2017.14 http://journals.tbzmed.ac.ir/jcvtr TUOMS Publishing Group Original Article Correlation between severity of ultrasonographic nonalcoholic
More informationHbA1c AS AN INDEX OF GLYCEMIC STATUS IN OBESE TYPE 2 DIABETICS
Original Article HbA1c AS AN INDEX OF GLYCEMIC STATUS IN OBESE TYPE 2 DIABETICS Shabana S1, Ramya K1, Sasisekhar T.V.D2, Santosh Kumar A2 1 Department of Biochemistry, Dr PSIMS & RF, Gannavaram, Andhra
More informationJMSCR Vol 06 Issue 12 Page December 2018
www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i12.63 Insulinemic Status and Nonalcoholic
More informationScreening cardiac patients for advanced liver disease
HKASLD 30 th ASM and International Symposium on Hepatology 2017 Screening cardiac patients for advanced liver disease 5 Nov 2017 Dr. Lau Yue Leung Joulen Pamela Youde Nethersole Eastern Hospital NAFLD
More informationSANDRA LILIANA JIMÉNEZ RESTREPO, M.D. HUGO A. FAJARDO, M.D. ALBA RODRÍGUEZ, M.D. NATIONAL UNIVERSITY OF COLOMBIA BOGOTÁ, COLOMBIA 2013
SANDRA LILIANA JIMÉNEZ RESTREPO, M.D. HUGO A. FAJARDO, M.D. ALBA RODRÍGUEZ, M.D. NATIONAL UNIVERSITY OF COLOMBIA BOGOTÁ, COLOMBIA 213 I have no financial relationships to disclose. I will not discuss off-label
More informationCorrelation between bright echogenic liver, elevated liver enzymes and liver histology.
Original Article Correlation between bright echogenic liver, elevated liver enzymes and liver histology. Dr. Iqbal Murshed Kabir, Dr. Mahbub Alam, Dr. Mohammad Mahmuduzzaman, Dr. Abdullah Al Mamoon, Dr.
More information대사증후군과알라닌아미노전이효소와의관련성 : 국민건강영양조사제 3 기 (2005 년 )
원저 대사증후군과알라닌아미노전이효소와의관련성 : 국민건강영양조사제 3 기 (2005 년 ) 한미아류소연박종강명근김기순 조선대학교의과대학예방의학교실 조선대학교내성세포연구센터 서론 alcoholic steatohepatitis NASH) 2 2 [1] 2001 NCEP-ATP III Panel [2] (nonalcoholic fatty liver disease
More informationA study of effect of alcohol on liver function tests (LFT) in Garhwal hills, India
International Journal of Research in Medical Sciences Gogoi JB et al. Int J Res Med Sci. 2018 Jan;6(1):94-98 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Original Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20175536
More informationNAFLD AND TYPE 2 DIABETES
NAFLD AND TYPE 2 DIABETES Sonia Caprio, MD STOPNASH Symposium on the Origin and Pathways of Nonalcoholic Steatohepatitis Washington 7, 215 Global Projection of Diabetes Hossain P et al. N Engl J Med 27;356:213
More informationyear resident, Department of Medicine, B. J. Medical college, Ahmedabad.
Clinical Study of Type 2 Diabetes Mellitus Patients with or without Cerebrovascular Feature and Its Correlation with Other Comorbidity / Diabetic Complication Vivek Sidhapura 1*, Bipin Amin 2, Amit Potulwar
More informationFATTY LIVER IN OVERWEIGHT AND OBESE PATIENTS IN WESTERN PART OF SAUDI ARABIA: A study of sonological prevalence
FATTY LIVER IN OVERWEIGHT AND OBESE PATIENTS IN WESTERN PART OF SAUDI ARABIA: A study of sonological prevalence Qari FA 1 & Al-Ghamdi A 2 ABSTRACT Objective: The aim of the study was to determine the association
More informationA study of waist hip ratio in identifying cardiovascular risk factors at Government Dharmapuri College Hospital
Original Research Article A study of waist hip ratio in identifying cardiovascular risk factors at Government Dharmapuri College Hospital M. Arivumani * Assistant Professor of General Medicine, Government
More informationNon-alcoholic fatty liver disease (NAFLD) is a
Original Article / Liver Hepatobiliary & Pancreatic Diseases International The association of non-alcoholic fatty liver disease and metabolic syndrome in a Chinese population Shou-Wu Lee, Teng-Yu Lee,
More informationNON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON- ALCOHOLIC STEATOHEPATITIS (NASH) IN ASIAN-PACIFIC REGION
SL 2-1 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON- ALCOHOLIC STEATOHEPATITIS (NASH) IN ASIAN-PACIFIC REGION Mikio KAJIHARA 1,3, Yoshinori HORIE 2,3, Hiromasa ISHII 3 1 Tokyu Hospital, 2 Eiju General
More informationHypertriglyceridemia and the Related Factors in Middle-aged Adults in Taiwan
1 Hypertriglyceridemia and the Related Factors in Middle-aged Adults in Taiwan Cheng-Chieh Lin, Tsai-Chung Li 2, Shih-Wei Lai, Kim-Choy Ng 1, Kuo-Che Wang, Chiu-Shong Liu Department of Community Medicine,
More informationWaist hip ratio in early pregnancy as a clinical indicator of serum lipid levels and predictor of pregnancy complications
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Khare D et al. Int J Reprod Contracept Obstet Gynecol. 2016 Jun;5(6):1709-1713 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
More informationZhengtao Liu 1,2,3*, Shuping Que 4*, Lin Zhou 1,2,3 Author affiliation:
Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: AMeta-analysis of Prospective Studies Zhengtao Liu 1,2,3*, Shuping Que 4*, Lin Zhou
More informationPrevalence and Factors Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Korean Population
Gut and Liver, Vol. 10, No. 1, January 2016, pp. 117-125 ORiginal Article Prevalence and Factors Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Korean Population Hyun Chin Cho Division
More informationObesity in the pathogenesis of chronic disease
Portoroz October 16th 2013 Obesity in the pathogenesis of chronic disease Rocco Barazzoni University of Trieste Department of Medical, Surgical and Health Sciences Obesity Trends* Among U.S. Adults BRFSS,
More informationThyroid Function and Risk of Non-Alcoholic Fatty Liver Disease in Euthyroid Subjects
Thyroid function and NAFLD., 2018; 17 (5): 779-788 ORIGINAL ARTICLE September-October, Vol. 17 No. 5, 2018: 779-788 779 The Official Journal of the Mexican Association of Hepatology, the Latin-American
More informationPEDIATRIC FOIE GRAS: NON-ALCOHOLIC FATTY LIVER DISEASE
PEDIATRIC FOIE GRAS: NON-ALCOHOLIC FATTY LIVER DISEASE Updates on New insights into NAFLD and NASH pathophysiology New AASLD/AGA/ACG guidelines for NAFLD and NASH, as pertains to pediatrics Evidence-based
More informationEFFECT OF ORAL SUPPLEMENTATION OF WHEY PROTEIN ISOLATE ON NON-ALCOHOLIC STEATOHEPATITIS PATIENTS
42 EFFECT OF ORAL SUPPLEMENTATION OF WHEY PROTEIN ISOLATE ON NON-ALCOHOLIC STEATOHEPATITIS PATIENTS Prasong Tienboon MD, PhD. 1, Taned Chitapanarux MD. 2, Suwalee Pojchamarnwiputh MD. 3, Donrawee Leelarungrayub
More informationAssociation of hypothyroidism with metabolic syndrome - A case- control study
Article ID: ISSN 2046-1690 Association of hypothyroidism with metabolic syndrome - A case- control study Peer review status: No Corresponding Author: Dr. Veena K Karanth, Associate Professor, Surgery,
More informationUpdate on Non-Alcoholic Fatty Liver Disease. Timothy R. Morgan, MD Chief, Hepatology, VA Long Beach Professor of Medicine, UCI
Update on Non-Alcoholic Fatty Liver Disease Timothy R. Morgan, MD Chief, Hepatology, VA Long Beach Professor of Medicine, UCI February 3, 2018 Disclosure Clinical trials: Genfit Speaker s Bureau: none
More informationNASH PROGRESS IN THE LAST DECADE
PROGRESS IN THE LAST DECADE Mitchell L. Shiffman, MD, FACG Director Health System Richmond and Newport News, VA Medical Group Good Help to Those in Need A GLOBAL HEALTH PROBLEM Nigeria Australia Spain
More informationInternational Journal of Current Research and Academic Review ISSN: Volume 3 Number 9 (September-2015) pp
International Journal of Current Research and Academic Review ISSN: 2347-3215 Volume 3 Number 9 (September-2015) pp. 243-251 www.ijcrar.com Effect of Ursodeoxycholic acid on lipid profile in NAFLD patients
More informationNonalcoholic Steatohepatitis National Digestive Diseases Information Clearinghouse
Nonalcoholic Steatohepatitis National Digestive Diseases Information Clearinghouse National Institute of Diabetes and Digestive and Kidney Diseases NATIONAL INSTITUTES OF HEALTH Nonalcoholic steatohepatitis
More informationUpdate on Nonalcoholic Fatty Liver Disease. Kathleen E Corey, MD, MPH, MMSc Director, Mass General Fatty Liver Clinic
Update on Nonalcoholic Fatty Liver Disease Kathleen E Corey, MD, MPH, MMSc Director, Mass General Fatty Liver Clinic Outline Defining the phenotypes of nonalcoholic fatty liver disease NAFLD Diagnostics
More informationA comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus
Original Research Article A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus Deepa Kalikavil Puthenveedu 1, Sundaraj
More information